Moreover, 22 patients in TCGA gastric cancer cohort were diagnosed with MSI-H and had no MMR gene mutations, whereas 19 (86.36%) had at least one mutation in any DDR gene (except TP53). The gene discussed is TP53; the disease is gastric cancer.